Skip to content
Awesome – Lifestyle
Author:
Antengene Corporation Limited
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
June 9, 2026
Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026
June 3, 2026
←
Previous Page
1
2